STOCK TITAN

LIAN Stock Price, News & Analysis

LIAN NASDAQ

Company Description

LIAN (NASDAQ: LIAN) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

LIAN stock has declined 80.7% over the past year.

This page provides a comprehensive overview of LIAN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-80.73%
Performance 1 year

LIAN (LIAN) stock. Over the past 12 months, the stock has lost 80.7%.

Latest News

LIAN has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include management, earnings, clinical trial. View all LIAN news →

SEC Filings

No SEC filings available for LIAN.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

LIAN Company Profile & Sector Positioning

LIAN (LIAN) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.